Systemic mastocytosis with acute myeloid leukemia occurs from mutually exclusive clones expressing KITD816V and FLT3-ITD

被引：1
|
作者：
Capo-Chichi, Jose-Mario [1 ,2 ]
Kagotho, Elizabeth [1 ]
Nayyar, Rakesh [1 ]
Zhao, Davidson [1 ]
Minden, Mark [2 ]
Chang, Hong [1 ,2 ]
机构：
[1] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada
[2] Univ Hlth Network, Dept Hematol & Med Oncol, Toronto, ON, Canada
来源：
LEUKEMIA | 2021年 / 35卷 / 01期
关键词：
KIT D816V; MUTATIONS; DISTINCT;
D O I：
10.1038/s41375-020-01073-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：282 / 285
页数：4
相关论文
共 50 条
  • [41] Loss of Heterozygosity of FLT3-ITD Is Common in Acute Myeloid Leukemia and May be a More Consistent Prognostic Marker Than FLT3-ITD Allele Frequency
    Severson, Eric A.
    Sokol, Ethan S.
    Madison, Russell
    Duncan, Daniel
    Hemmerich, Amanda
    Edgerly, Claire
    Huang, Richard
    Britt, Nicholas
    Vergilio, Jo-Anne
    Elvin, Julia A.
    Reddy, Prasanth
    Sathyan, Pratheesh
    Alexander, Brian
    Ross, Jeffrey S.
    Ali, Siraj M.
    Ramkissoon, Shakti H.
    BLOOD, 2019, 134
  • [42] Symptomatic patients with hyperleukocytic FLT3-ITD wildtype acute myeloid myeloid leukemia do not benefit from leukapheresis
    Farid, Kiavasch Mohammad Nejad
    Sauer, Tim
    Schmitt, Michael
    Muller-Tidow, Carsten
    Schmitt, Anita
    ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 : 122 - 122
  • [43] Complete resolution of leukemia cutis with sorafenib in an acute myeloid leukemia patient with FLT3-ITD mutation
    Lee, Sung Ho
    Paietta, Elisabeth
    Racevskis, Janis
    Wiernik, Peter H.
    AMERICAN JOURNAL OF HEMATOLOGY, 2009, 84 (10) : 701 - 702
  • [44] TARGETING INTRACELLULAR TRAFFICKING OF FLT3-ITD AND KIT D816V BY CHLORPROMAZINE SHOWS PROMISING PRECLINICAL ACTIVITY AGAINST ACUTE MYELOID LEUKEMIA CELLS
    Rai, Shinya
    Tanaka, Hirokazu
    Watanabe, Toshio
    Kanakura, Yuzuru
    Matsumura, Itaru
    EXPERIMENTAL HEMATOLOGY, 2015, 43 (09) : S90 - S90
  • [45] Autophagy activation mediates resistance to FLT3 inhibitors in acute myeloid leukemia with FLT3-ITD mutation
    Dan Xu
    Yishan Chen
    Ying Yang
    Zhao Yin
    Changfen Huang
    Qiang Wang
    Ling Jiang
    Xuejie Jiang
    Changxin Yin
    Qifa Liu
    Guopan Yu
    Journal of Translational Medicine, 20
  • [46] Autophagy activation mediates resistance to FLT3 inhibitors in acute myeloid leukemia with FLT3-ITD mutation
    Xu, Dan
    Chen, Yishan
    Yang, Ying
    Yin, Zhao
    Huang, Changfen
    Wang, Qiang
    Jiang, Ling
    Jiang, Xuejie
    Yin, Changxin
    Liu, Qifa
    Yu, Guopan
    JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (01)
  • [47] Distinct Metabolic features differentiating FLT3-ITD AML from FLT3-WT childhood Acute Myeloid Leukemia
    Bradley Stockard
    Timothy Garrett
    Joy Guingab-Cagmat
    Soheil Meshinchi
    Jatinder Lamba
    Scientific Reports, 8
  • [48] Chronic FLT3-ITD Signaling in Acute Myeloid Leukemia Is Connected to a Specific Chromatin Signature
    Cauchy, Pierre
    James, Sally R.
    Zacarias-Cabeza, Joaquin
    Ptasinska, Anetta
    Imperato, Maria Rosaria
    Assi, Salam A.
    Piper, Jason
    Canestraro, Martina
    Hoogenkamp, Maarten
    Raghavan, Manoj
    Loke, Justin
    Akiki, Susanna
    Clokie, Samuel J.
    Richards, Stephen J.
    Westhead, David R.
    Griffiths, Michael J.
    Ott, Sascha
    Bonifer, Constanze
    Cockerill, Peter N.
    CELL REPORTS, 2015, 12 (05): : 821 - 836
  • [49] A dual inhibitor overcomes drug-resistant FLT3-ITD acute myeloid leukemia
    Peihong Wang
    Xinhua Xiao
    Yuyin Zhang
    Baoyuan Zhang
    Donghe Li
    Mingzhu Liu
    Xi Xie
    Chenxuan Liu
    Ping Liu
    Ruibao Ren
    Journal of Hematology & Oncology, 14
  • [50] Improved clinical outcome of acute myeloid leukemia with FLT3-ITD mutation treated with sorafenib
    顾斌
    ChinaMedicalAbstracts(InternalMedicine), 2016, 33 (02) : 56 - 57
12345